PRA Health Sciences Company Profile (NASDAQ:PRAH)

About PRA Health Sciences

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. The Company's integrated services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The Company's service offerings include Product Registration Services, which includes Phase IIb through III product registration trials and Phase IV trials, inclusive of post-marketing commitments and registries; Strategic Solutions, which provides Embedded Solutions and functional outsourcing services, and Early Development Services, which includes Phase I through Phase IIa clinical trials and bioanalytical laboratory services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PRAH
  • CUSIP:
Key Metrics:
  • Previous Close: $61.02
  • 50 Day Moving Average: $58.00
  • 200 Day Moving Average: $54.92
  • 52-Week Range: $39.25 - $61.92
  • Trailing P/E Ratio: 57.57
  • Foreward P/E Ratio: 16.90
  • P/E Growth: 1.04
  • Market Cap: $3.76B
  • Outstanding Shares: 61,597,000
  • Beta: 0.54
Profitability:
  • Net Margins: 4.86%
  • Return on Equity: 21.25%
  • Return on Assets: 6.86%
Debt:
  • Debt-to-Equity Ratio: 1.20%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.25%
Additional Links:
Companies Related to PRA Health Sciences:

Analyst Ratings

Consensus Ratings for PRA Health Sciences (NASDAQ:PRAH) (?)
Ratings Breakdown: 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $59.29 (2.84% downside)

Analysts' Ratings History for PRA Health Sciences (NASDAQ:PRAH)
Show:
DateFirmActionRatingPrice TargetDetails
2/27/2017Avondale PartnersUpgradeUnderperform -> Market Perform$63.00View Rating Details
2/23/2017Jefferies Group LLCReiterated RatingBuy$66.00View Rating Details
2/6/2017Credit Suisse GroupUpgradeNeutral -> Outperform$67.00View Rating Details
11/4/2016KeyCorpReiterated RatingBuyView Rating Details
9/22/2016Citigroup Inc.Boost Price TargetBuy$55.00 -> $66.00View Rating Details
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00View Rating Details
3/28/2016SunTrust Banks, Inc.UpgradeNeutral -> Buy$47.00 -> $51.00View Rating Details
11/3/2015Robert W. BairdBoost Price TargetOutperform$47.00 -> $49.00View Rating Details
8/21/2015William BlairReiterated RatingOutperformView Rating Details
(Data available from 2/28/2015 forward)

Earnings

Earnings History for PRA Health Sciences (NASDAQ:PRAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017        
2/22/2017Q4 2016$0.64$0.71$405.04 million$413.61 millionViewN/AView Earnings Details
11/2/2016Q316$0.64$0.64$394.87 million$399.80 millionViewN/AView Earnings Details
7/28/2016Q2$0.59$0.63$381.25 million$394.20 millionViewListenView Earnings Details
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PRA Health Sciences (NASDAQ:PRAH)
Current Year EPS Consensus Estimate: $3.04 EPS
Next Year EPS Consensus Estimate: $3.61 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.47$0.51$0.49
Q2 20162$0.56$0.59$0.58
Q3 20164$0.62$0.63$0.62
Q4 20163$0.63$0.69$0.65
Q1 20171$0.66$0.66$0.66
Q2 20172$0.68$0.79$0.74
Q3 20171$0.81$0.81$0.81
Q4 20171$0.77$0.77$0.77
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PRA Health Sciences (NASDAQ:PRAH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PRA Health Sciences (NASDAQ:PRAH)
Insider Ownership Percentage: 2.50%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/23/2017Colin ShannonCEOSell100,000$61.50$6,150,000.00View SEC Filing  
8/22/2016Colin ShannonCEOSell113,133$51.57$5,834,268.81View SEC Filing  
8/15/2016Linda BaddourVPSell69,380$52.00$3,607,760.00View SEC Filing  
8/12/2016David W. DockhornVPSell107,257$49.00$5,255,593.00View SEC Filing  
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PRA Health Sciences (NASDAQ:PRAH)
DateHeadline
capitalcube.com logoPRA Health Sciences, Inc. :PRAH-US: Earnings Analysis: 2016 By the Numbers : February 27, 2017 (NASDAQ:PRAH)
www.capitalcube.com - February 27 at 4:10 PM
News IconPRA Health Sciences Inc PRAH Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:PRAH)
www.bioportfolio.com - February 27 at 9:43 AM
News IconThe Technicals For PRA Health Sciences, Inc. (PRAH) Tell An ... - NY Stock News (NASDAQ:PRAH)
nystocknews.com - February 25 at 1:32 AM
capitalcube.com logoPRA Health Sciences, Inc. :PRAH-US: Earnings Analysis: Q4, 2016 By the Numbers : February 24, 2017 (NASDAQ:PRAH)
www.capitalcube.com - February 24 at 8:32 PM
News IconMarket Focus: Checking in on Shares of PRA Health Sciences Inc (PRAH) - Searcy News (NASDAQ:PRAH)
searcysentinel.com - February 24 at 8:25 AM
News IconPRA Health Sciences, Inc. (NASDAQ:PRAH) – Fast Growth Play with Potential Stock Upside - Winfield Review (NASDAQ:PRAH)
winfieldreview.com - February 24 at 8:25 AM
News IconStock Buzz on PRA Health Sciences, Inc. (NASDAQ:PRAH): Can They Meet the Earnings Target of $0.64 - Winfield Review (NASDAQ:PRAH)
winfieldreview.com - February 24 at 8:25 AM
nasdaq.com logoPRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 ... - Nasdaq (NASDAQ:PRAH)
www.nasdaq.com - February 24 at 8:25 AM
us.rd.yahoo.com logoEdited Transcript of PRAH earnings conference call or presentation 23-Feb-17 2:00pm GMT (NASDAQ:PRAH)
us.rd.yahoo.com - February 24 at 12:25 AM
4-traders.com logoPRA HEALTH SCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) (NASDAQ:PRAH)
www.4-traders.com - February 23 at 7:24 PM
seekingalpha.com logoPRA Health Sciences' (PRAH) CEO Colin Shannon on Q4 2016 Results - Earnings Call Transcript (NASDAQ:PRAH)
seekingalpha.com - February 23 at 7:24 PM
biz.yahoo.com logoPRA HEALTH SCIENCES, INC. Files SEC form 10-K, Annual Report (NASDAQ:PRAH)
biz.yahoo.com - February 23 at 7:24 PM
streetinsider.com logoPRA Health Sciences (PRAH) Tops Q4 EPS by 7c (NASDAQ:PRAH)
www.streetinsider.com - February 23 at 8:52 AM
seekingalpha.com logoPRA Health Q4 top line up 10%; earnings down 51%; shares ease 1% after hours (NASDAQ:PRAH)
seekingalpha.com - February 22 at 7:27 PM
News IconPRA Health Sciences Inc (PRAH): Poised for Long-Term Success? (NASDAQ:PRAH)
simplywall.st - February 22 at 7:27 PM
us.rd.yahoo.com logoPRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance (NASDAQ:PRAH)
us.rd.yahoo.com - February 22 at 7:27 PM
biz.yahoo.com logoPRA HEALTH SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:PRAH)
us.rd.yahoo.com - February 22 at 7:27 PM
us.rd.yahoo.com logo4:03 pm PRA Health Sciences beats by $0.07, beats on revs; guides Q1 EPS below consensus, revs in-line; guides FY17 EPS above consensus, revs above consensus (NASDAQ:PRAH)
us.rd.yahoo.com - February 22 at 7:27 PM
sg.finance.yahoo.com logoPRA Health Sciences beats Street 4Q forecasts (NASDAQ:PRAH)
sg.finance.yahoo.com - February 22 at 7:27 PM
bizjournals.com logoRaleigh's PRA Health Sciences gains 60 employees after Takeda deal (NASDAQ:PRAH)
www.bizjournals.com - February 16 at 6:57 PM
bizjournals.com logoRaleigh's PRA Health Sciences gains 60 employees after Takeda deal (NASDAQ:PRAH)
www.bizjournals.com - February 16 at 6:57 PM
4-traders.com logoTakeda Pharmaceutical : PRA Health Sciences and Takeda Partnership Expands to Japan (NASDAQ:PRAH)
www.4-traders.com - February 15 at 4:48 AM
News IconPRA Health Sciences, Inc. (PRAH) Shares Active after Upgrade at Credit Suisse Group - The Ledger Gazette (NASDAQ:PRAH)
ledgergazette.com - February 8 at 8:57 PM
us.rd.yahoo.com logoPRA Health Sciences upgraded by Credit Suisse (NASDAQ:PRAH)
us.rd.yahoo.com - February 6 at 7:24 PM
finance.yahoo.com logoAnalysts' Actions -- Cabot, International Paper, Range Resources and More (NASDAQ:PRAH)
finance.yahoo.com - February 6 at 9:01 AM
feeds.benzinga.com logoPRA Health Sciences to Report Fourth Quarter 2016 Earnings and Issue 2017 Guidance (NASDAQ:PRAH)
feeds.benzinga.com - February 2 at 5:37 PM
News IconWatching ADX Levels for Pra Health Sciences Inc. (PRAH) - Market Point (NASDAQ:PRAH)
mtptnews.com - January 29 at 12:29 AM
nasdaq.com logoFirst Week of February 17th Options Trading For PRA Health Sciences (PRAH) (NASDAQ:PRAH)
www.nasdaq.com - January 28 at 5:46 AM
News IconGoing The Extra Mile: Stock With Track Record & Upside: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Wall Street Beacon (NASDAQ:PRAH)
wsbeacon.com - January 27 at 1:18 AM
capitalcube.com logoPRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : January 25, 2017 (NASDAQ:PRAH)
www.capitalcube.com - January 26 at 1:53 AM
News IconStock Tracker: Earnings & Estimates for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Aiken Advocate (NASDAQ:PRAH)
aikenadvocate.com - January 25 at 1:09 AM
capitalcube.com logoPRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : January 24, 2017 (NASDAQ:PRAH)
www.capitalcube.com - January 24 at 8:29 AM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Wall Street Beacon (NASDAQ:PRAH)
wsbeacon.com - January 22 at 12:04 AM
News IconSteady As She Goes, Accelerated Growth Puts Stock in Focus: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Wall Street Beacon (NASDAQ:PRAH)
wsbeacon.com - January 21 at 1:13 AM
4-traders.com logoPRA Health Sciences : Research Reports Initiation on Healthcare Stocks -- PAREXEL, Charles River Laboratories, PRA Health Sciences, and Invitae (NASDAQ:PRAH)
www.4-traders.com - January 20 at 5:54 AM
finance.yahoo.com logoTop Ranked Growth Stocks to Buy for January 16th - Yahoo Finance (NASDAQ:PRAH)
finance.yahoo.com - January 18 at 12:45 AM
News IconWill The Needle Move For PRA Health Sciences, Inc. (NASDAQ:PRAH) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:PRAH)
wsbeacon.com - January 18 at 12:45 AM
News IconPRA Health Sciences Inc PRAH Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:PRAH)
www.bioportfolio.com - January 15 at 6:51 PM
News IconWalking the Extra Mile: What's Next For Shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) - Wall Street Beacon (NASDAQ:PRAH)
wsbeacon.com - January 14 at 4:43 AM
investornewswire.com logoSentiments And Ratings Alert: PRA Health Sciences, Inc. (NASDAQ:PRAH) - Investor Newswire (NASDAQ:PRAH)
www.investornewswire.com - January 5 at 3:20 PM
investornewswire.com logoPRA Health Sciences, Inc. (NASDAQ:PRAH) Strong Buy Recommendations At 6 - Investor Newswire (NASDAQ:PRAH)
www.investornewswire.com - January 2 at 8:31 AM
capitalcube.com logoETFs with exposure to PRA Health Sciences, Inc. : December 29, 2016 (NASDAQ:PRAH)
www.capitalcube.com - December 29 at 7:17 PM
investornewswire.com logoPRA Health Sciences, Inc. (NASDAQ:PRAH) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:PRAH)
www.investornewswire.com - December 25 at 6:38 PM
capitalcube.com logoPRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : December 23, 2016 (NASDAQ:PRAH)
www.capitalcube.com - December 23 at 7:31 AM
investornewswire.com logoPRA Health Sciences, Inc. (NASDAQ:PRAH) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:PRAH)
www.investornewswire.com - December 22 at 7:39 PM
investornewswire.com logoAnalyst Rating Of PRA Health Sciences, Inc. (NASDAQ:PRAH ... - Investor Newswire (NASDAQ:PRAH)
www.investornewswire.com - December 18 at 12:51 AM
capitalcube.com logoPRA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PRAH-US : December 12, 2016 (NASDAQ:PRAH)
www.capitalcube.com - December 12 at 9:38 AM
reuters.com logoBRIEF-PRA Health Sciences' unit entered into a credit agreement on Dec. 6 (NASDAQ:PRAH)
www.reuters.com - December 8 at 12:16 AM
marketexclusive.com logoPRA Health Sciences,Inc. (NASDAQ:PRAH) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:PRAH)
marketexclusive.com - December 8 at 12:16 AM
marketexclusive.com logoHome SEC Filings PRA Health Sciences,Inc. (NASDAQ:PRAH) Files An 8-K Entry into a Material Definitive... - Market Exclusive (NASDAQ:PRAH)
marketexclusive.com - December 7 at 9:14 AM

Social

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

Where is PRA Health Sciences' stock going? Where will PRA Health Sciences' stock price be in 2017?

7 brokerages have issued twelve-month price targets for PRA Health Sciences' shares. Their predictions range from $47.00 to $67.00. On average, they expect PRA Health Sciences' stock price to reach $59.29 in the next twelve months.

When will PRA Health Sciences announce their earnings?

PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

What are analysts saying about PRA Health Sciences stock?

Here are some recent quotes from research analysts about PRA Health Sciences stock:

  • According to Zacks Investment Research, "PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina. " (11/9/2016)

  • KeyCorp analysts commented, "By our models, the strength of PRAH's backlog (up 16 percent YOY) and bookings (1.25xR4Q) sets up for above-consensus performance," analyst Donald Hooker wrote in a note.Hooker expects constant currency revenue growth of 13.8 percent in 2016 (consensus: 12.7 percent) and 10.9 percent in 2017 (consensus: 9.5 percent), which should boost profit margins. The analyst forecast 2016 EPS of $2.46 (consensus: $2.43), and 2017 EPS of $2.96 (consensus: $2.82).Related Link: Raymond James Sees Lingering Risks At OraSure, DowngradesEven assuming a modest slowdown in backlog conversion, we think revenues should come in toward the high end of management's 2016 guidance with significant backlog left over for a strong 2017 and 2018," Hooker highlighted.Other Expectations For PRA HealthThe analyst also models EBITDA growth of almost 13 percent in 2017, which is well above the peer group average about 10 percent.In addition, the analyst noted that investors under appreciate the bookings strength from PRA Health's investments in analytics that include Predictivv cloud-based technology platform and its recent acquisition of Nextrials, an electric data capture (EDC) vendor. Hooker said, "Management has been developing retroactive and predictive algorithms over the past eight years, and we believe this work may now be starting to show up in bookings."[M]anagement has recently addressed PRAH's indebtedness and ownership concentration, which reduces two of the largest overhangs on the shares, in our view," (6/13/2016)

Who owns PRA Health Sciences stock?

PRA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Marshall Wace LLP (2.05%), Columbia Wanger Asset Management LLC (1.91%), FMR LLC (1.63%), Ranger Investment Management L.P. (1.21%), Alyeska Investment Group L.P. (1.11%) and Russell Investments Group Ltd. (1.02%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour and Pra Investors LP Kkr.

Who sold PRA Health Sciences stock? Who is selling PRA Health Sciences stock?

PRA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Two Sigma Investments LP, Loomis Sayles & Co. L P, Turner Investments LLC, Guggenheim Capital LLC, GSA Capital Partners LLP, Cipher Capital LP and Tudor Investment Corp Et Al. Company insiders that have sold PRA Health Sciences stock in the last year include Colin Shannon, David W Dockhorn, Linda Baddour and Pra Investors LP Kkr.

Who bought PRA Health Sciences stock? Who is buying PRA Health Sciences stock?

PRA Health Sciences' stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Marshall Wace LLP, Alyeska Investment Group L.P., Columbia Wanger Asset Management LLC, Allianz Asset Management AG, Dimensional Fund Advisors LP, Ranger Investment Management L.P. and Axiom International Investors LLC DE.

How do I buy PRA Health Sciences stock?

Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of PRA Health Sciences stock cost?

One share of PRA Health Sciences stock can currently be purchased for approximately $61.02.

PRA Health Sciences (NASDAQ:PRAH) Chart for Tuesday, February, 28, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Earnings History Chart

Earnings by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Dividend History Chart

Dividend Payments by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Last Updated on 2/28/2017 by MarketBeat.com Staff